Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science
|
December 3, 2016
Authors' reply
Patrick Keown, Orla McBride, Liz Twigg, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 11, 2016
Rates of voluntary and compulsory psychiatric in-patient treatment in England: an ecological study investigating associations with deprivation and demographics
Patrick Keown, Orla McBride, Liz Twigg, et al.
The Lancet. Psychiatry
|
June 26, 2017
Variation in compulsory psychiatric inpatient admission in England: a cross-classified, multilevel analysis
Scott Weich, Orla McBride, Liz Twigg, et al.
Psychological Medicine
|
May 20, 2021
Effects of ethnic density on the risk of compulsory psychiatric admission for individuals attending secondary care mental health services: evidence from a large-scale study in England
Orla McBride, Craig Duncan, Liz Twigg, et al.
BMJ Open
|
October 21, 2018
Evaluating the effects of community treatment orders (CTOs) in England using the Mental Health Services Dataset (MHSDS): protocol for a national, population-based study
Scott Weich, Craig Duncan, Kamaldeep Bhui, et al.
Journal of Evaluation in Clinical Practice
|
July 31, 2019
Moving beyond randomized controlled trials in the evaluation of compulsory community treatment
Craig Duncan, Scott Weich, Graham Moon, et al.
Bjpsych Open
|
August 15, 2020
Understanding increasing rates of psychiatric hospital detentions in England: development and preliminary testing of an explanatory model
Luke Sheridan Rains, Scott Weich, Clementine Maddock, et al.
Therapeutic Advances in Psychopharmacology
|
July 7, 2018
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
Thomas R E Barnes, Verity Leeson, Carol Paton, et al.
Health Technology Assessment (Winchester, England)
|
September 5, 2017
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Thomas Re Barnes, Verity C Leeson, Carol Paton, et al.
Health Technology Assessment (Winchester, England)
|
April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Thomas R E Barnes, Verity C Leeson, Carol Paton, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
The British Journal of Psychiatry : the Journal of Mental Science
|
December 3, 2016
Authors' reply
Patrick Keown, Orla McBride, Liz Twigg, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 11, 2016
Rates of voluntary and compulsory psychiatric in-patient treatment in England: an ecological study investigating associations with deprivation and demographics
Patrick Keown, Orla McBride, Liz Twigg, et al.
The Lancet. Psychiatry
|
June 26, 2017
Variation in compulsory psychiatric inpatient admission in England: a cross-classified, multilevel analysis
Scott Weich, Orla McBride, Liz Twigg, et al.
Psychological Medicine
|
May 20, 2021
Effects of ethnic density on the risk of compulsory psychiatric admission for individuals attending secondary care mental health services: evidence from a large-scale study in England
Orla McBride, Craig Duncan, Liz Twigg, et al.
BMJ Open
|
October 21, 2018
Evaluating the effects of community treatment orders (CTOs) in England using the Mental Health Services Dataset (MHSDS): protocol for a national, population-based study
Scott Weich, Craig Duncan, Kamaldeep Bhui, et al.
Journal of Evaluation in Clinical Practice
|
July 31, 2019
Moving beyond randomized controlled trials in the evaluation of compulsory community treatment
Craig Duncan, Scott Weich, Graham Moon, et al.
Bjpsych Open
|
August 15, 2020
Understanding increasing rates of psychiatric hospital detentions in England: development and preliminary testing of an explanatory model
Luke Sheridan Rains, Scott Weich, Clementine Maddock, et al.
Therapeutic Advances in Psychopharmacology
|
July 7, 2018
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
Thomas R E Barnes, Verity Leeson, Carol Paton, et al.
Health Technology Assessment (Winchester, England)
|
September 5, 2017
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Thomas Re Barnes, Verity C Leeson, Carol Paton, et al.
Health Technology Assessment (Winchester, England)
|
April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Thomas R E Barnes, Verity C Leeson, Carol Paton, et al.
Page
of 4